The Claim
In male patients with tophaceous gout undergoing uric acid-lowering therapy for approximately 3.8 years, ultrasound-measured tophi volume decreased by an average of 23% from baseline, with the greatest reduction observed after the fourth annual measurement.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In men with tophaceous gout receiving treatment to lower uric acid levels over nearly four years, the size of uric acid crystal deposits measured by ultrasound decreased by 23% on average, with the largest reduction occurring after the fourth year of treatment.
See the scientific wording
In 11 male patients with tophaceous gout undergoing uric acid-lowering therapy over approximately 3.8 years, ultrasound-measured tophi volume decreased by an average of 23% from baseline, with the most significant reduction occurring after the fourth annual measurement, suggesting a time-dependent response to sustained uric acid reduction.
When uric acid levels in the blood drop below a certain point, the hard uric acid crystals under the skin start to dissolve. These dissolved crystals are then eaten up and removed by special immune cells, causing the lumps to shrink over time. The longer uric acid stays low, the more crystals disappear, which is why the biggest reduction happens after several years.
What the research says
1 studyIn 11 men with gout, doctors used ultrasound to watch uric acid lumps under the skin shrink slowly over four years — the longer they took medicine to lower uric acid, the more the lumps disappeared.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.